Skip to main content

Table 2 Adjusted prevalences and population estimates of health outcomes in the United States 1999-March 2020, by HIV infection status

From: Comparison of healthspan-related indicators between adults with and without HIV infection aged 18–59 in the United States: a secondary analysis of NAHNES 1999–March 2020

Outcomes

 

Persons with HIV

 

Persons without HIV

Prevalence Difference,

% (95%CI)

P-Value*

n/Na

Prevalenceb,

% (95%CI)

Estimated Populationc

n/Na

Prevalenceb,

% (95%CI)

Estimated Populationc

  

Physical Frailty

50/170

28.9 (28.8, 29.0)

330 147

3 705/32 878

10.4 (10.4, 10.4)

28 419 884

18.5 (18.4, 18.6)

 < 0.001

ADL Disability

36/70

59.7 (59.5, 60.0)

246 540

2 014/5 127

36.3 (36.3, 36.3)

16 514 816

23.4 (23.2, 23.7)

 < 0.001

Mobility Disability

59/70

84.3 (84.0, 84.5)

392 823

3 689/5 127

69.8 (69.7, 69.8)

31 757 450

14.5 (14.2, 14.8)

 < 0.001

Depression

52/122

41.9 (41.7, 42.0)

414 507

5 725/24 167

22.4 (22.4, 22.4)

47 676 267

19.5 (19.3, 19.6)

 < 0.001

Multimorbidity

43/170

18.9 (18.8, 19.0)

280 525

3 619/22 030

12.0 (12.0, 12.0)

32 465 944

6.9 (6.8, 7.0)

 < 0.001

All-cause Death

29/170

17.4 (17.4, 17.5)

179 588

961/32 968

2.7 (2.7, 2.7)

7 443 135

14.7 (14.6, 14.8)

 < 0.001

  1. Abbreviations: CI 95% confidence interval, ADL activities of daily living
  2. aNumber for both numerator and denominator were based on unweighted study samples
  3. bPrevalence, % and (95% CI) were calculated by marginal structural models using an inverse-probability-of-exposure weight adjusted for age, sex, ethnicity and education
  4. cRefers to weighted number of n case, which were calculated from weighted estimates, eg., 50 represented 330,147 population with HIV suffered with physical frailty, 3,705 represented 28,419,884 population without HIV suffered with physical frailty; Weighted numbers of N population were also calculated, eg., 170 represented 1,184,357 population with HIV, 32,878 represented 273,794,954 US adults
  5. *P value was obtained from the marginal structural model method (see in the Analyses section) between with HIV vs. without HIV